Patent details

LUC00137 Product Name: Avatrombopag ou ses sels pharmaceutiquement acceptables, en particulier le maléate d'avatrombopag

Basic Information

Publication number:
LUC00137
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP037005717
Legal Status:
Active
Application number:
LUC00137
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
09/01/2026
SPC Extension Agent Name:
ARONOVA S.A.
SPC Extension Status:
Pending & Published
SPC Extension Grant Date:
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/19/1373
Marketing Authorization Type:
Marketing Authorization Date:
24/06/2019
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
12/11/2019
First Marketing Authorization date:
24/06/2019
Grant date:
12/06/2020
Activation date:
15/01/2023
Publication date:
14/11/2019
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
15/01/2028
SPC Extension Expiration:
15/07/2028
Rejection date:
Withdrawal date:

Owner

From:
12/11/2019
 
 

Name:
Astellas Pharma Inc.
Address:
-, 5-1, Nihonbashi-honcho 2-chome, Chuo-ku, Tokyo 103-8411, Japan (JP)

Agent

Name:
ARONOVA S.A.
From:
12/11/2019
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2019/13
Publication date:
20/12/2019
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2020/08
Publication date:
13/07/2020
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
SPC3
Bulletin edition number:
2023/02
Publication date:
08/02/2023
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

4

Bulletin Heading:
SPCX1
Bulletin edition number:
2026/03
Publication date:
05/02/2026
Description:
Section G : Applications for extensions for pediatric use – I1E publication

Annual Fees

Annual Fee Due Date:
01/02/2027
Annual Fee Number:
25
Annual Fee Amount:
450 Euro
Expected Payer:
Last Annual Fee Payment Date:
21/01/2026
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
440 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages
12/11/2019 General Document 4
12/11/2019 Application Form 4
12/06/2020 Outgoing Correspondence 1
14/11/2019 Publication 1
12/11/2019 Incoming Correspondence (Post) 1
12/12/2019 Incoming Correspondence (Post) 1
14/11/2019 Outgoing Correspondence 1
12/11/2019 General Document 2
12/06/2020 Certificate 1
10/06/2020 Incoming Correspondence (Post) 1
12/06/2020 Publication 1
12/11/2019 Application Form 4
17/12/2019 Outgoing Correspondence 1
12/11/2019 General Document 24
09/01/2026 Outgoing Correspondence 2
09/01/2026 General Document 36
09/01/2026 General Document 5
09/01/2026 General Document 29
09/01/2026 Application Form 5
09/01/2026 General Document 1
13/01/2026 Outgoing Correspondence 1
12/01/2026 Publication 1
12/01/2026 FNET_DC_FRONTPAGE 1
12/01/2026 Outgoing Correspondence 1
09/01/2026 Paediatric investigation plan 29
16/01/2026 Outgoing Correspondence 1